Health Care

Pfizer expects to supply 50 million doses in 2020 and manufacture up to 1.3 billion doses in 2021.

Even for rich nations with developed vaccination programs, that presents a host of problems ranging including building new databases to track who is getting the shot, working out ways to encourage mass uptake among younger people, ensuring adequate supply and running large-scale inoculation centers where the shots can be safely and quickly administered.

Stock investors piled into cyclical names and out of growth

The U.S. Supreme Court is set to hear a case that could determine the future of the Affordable Care Act.

Pfizer and its German partner, BioNTech, said their COVID-19 vaccine proved to be 90% effective.

Pfizer said on Monday its experimental vaccine was more than 90% effective in preventing COVID-19 based on initial data from a large study. 

Stocks resumed their march higher on Monday after Pfizer's vaccine news and a Biden-Harris win.

Almost half, or 48%, of the nursing homes reported they hadn’t used their rapid-testing equipment in the most recent week included in the data.

The New York congresswoman said swing-seat Democrats who supported the proposal have been reelected.

Unlike last spring, state, local officials use targeted measures in hopes of stemming rising infections and hospitalizations

Chipotle is encountering a staffing dilemma as COVID-19 continues to sweep the nation and take out workers who have contracted the illness.

A panel of outside advisers to the U.S. Food and Drug Administration on Friday voted that a potential Alzheimer’s treatment from Biogen Inc has not been proven to slow progression of the disease, a sharp rebuke to agency staff that earlier this week praised the drug.

Rep. Alexandria Ocasio-Cortez rejected the narrative that progressive policy ideas cost Democrats seats in the House.

A panel of outside experts meets Friday to advise the Food and Drug Administration on aducanumab, a drug from Cambridge, Massachusetts-based Biogen Inc. and Japan’s Eisai Co. FDA doesn’t always follow the panel’s advice but usually does and has until March to decide.

AstraZeneca announced Wednesday that it still expects results from phase three of its COVID-19 vaccine trial to be ready by the end of 2020.

Across the country, several states reported record tallies of daily infections, including Indiana, Minnesota, Iowa, Colorado and Idaho.

The biotech giant is at a crossroads as it seeks regulatory approval for its potential blockbuster Alzheimer’s drug aducanumab, while facing down generic competition to its biggest-selling treatment.

J&J said it will set aside a $2.1 billion reserve for the verdict, to be reflected in its year-end financial results

Cruise lines had to cancel trips because of COVID-19 pandemic

Millions of Americans who have lost health insurance in an economy shaken by the coronavirus can sign up for taxpayer-subsidized coverage starting Sunday.